ARTICLE | Clinical News
MDCO-216: Phase I/II ongoing
September 5, 2016 7:00 AM UTC
An IDMC recommended continuation of the double-blind, placebo-controlled, international Phase I/II MILANO-PILOT trial evaluating 20 mg/kg IV MDCO-216 weekly for 5 weeks based on a planned interim anal...